Osteogenesis Imperfecta in Babies
The short answer
Osteogenesis imperfecta (OI), also known as brittle bone disease, is a genetic disorder affecting collagen production that makes bones extremely fragile. It affects about 1 in 15,000 to 20,000 births and ranges from mild (a few fractures over a lifetime) to severe (fractures occurring before birth). With careful management, bisphosphonate therapy, and adaptive strategies, children with OI can lead active and fulfilling lives.
By Age
What to expect by age
Severe forms of OI (Type II and III) are often diagnosed prenatally or at birth. Babies may be born with fractures, bowed limbs, a soft skull, and blue or gray sclera (the whites of the eyes). Type II is the most severe and can be fatal in the newborn period. Milder forms (Type I) may not be diagnosed at birth. If your baby sustains a fracture from normal handling, OI should be considered. Careful handling is essential — always support the head and body fully.
Babies with diagnosed OI need gentle handling by all caregivers. Diaper changes, lifting, and dressing require careful technique to avoid fractures. Despite the fragility, babies need interaction and stimulation for healthy development. Bisphosphonate therapy (pamidronate IV infusions) may be started in the first months of life for moderate to severe forms to strengthen bones. Blue sclera, if present, are a helpful diagnostic feature.
Motor development is often delayed because of bone fragility and the need to be cautious about falls. Physical therapy in a supportive environment (such as water therapy) helps build strength safely. Hearing should be monitored, as OI can cause hearing loss. Dental evaluation may reveal translucent teeth (dentinogenesis imperfecta) in some types. Safe positioning and adaptive equipment support developmental progress.
As children with OI grow, fracture frequency often decreases somewhat. Walking may be delayed, and some children with severe forms may use wheelchairs or braces. Mild forms (Type I) may allow typical mobility with reasonable precautions. Ongoing bisphosphonate therapy, orthopedic monitoring, and physical therapy continue. With appropriate support, children with OI can attend school, have friendships, and participate in adapted activities.
What Should You Do?
When to take action
- Your baby with mild OI (Type I) has had only a few fractures and is growing well
- Your baby's blue sclera are a cosmetic feature of Type I OI and do not affect vision
- Your baby is on bisphosphonate therapy and fracture frequency has decreased
- Your baby is meeting developmental milestones, even if motor milestones are delayed or adapted
- Your baby has had an unexplained fracture from minimal or no apparent trauma
- Your baby has blue sclera, a family history of frequent fractures, or signs of bone fragility
- Your baby with OI seems to be in pain or has swelling in a limb that could indicate a new fracture
- Your baby has sustained a fracture — seek medical care for proper splinting and pain management
- Your baby has difficulty breathing after a rib fracture, or has a head injury with a skull fracture — these require emergency evaluation
Sources
Related Resources
Related Medical Concerns
My Baby's Head Shape Looks Abnormal
Many babies develop temporary head shape irregularities that are completely normal. A cone-shaped head from vaginal delivery reshapes within days. Mild positional flattening (plagiocephaly) from sleeping on the back is very common and usually improves with repositioning and tummy time. However, head shape changes involving ridges, a persistently bulging fontanelle, or rapid head growth changes should be evaluated to rule out craniosynostosis.
Achondroplasia (Dwarfism) in Babies
Achondroplasia is the most common form of short-limbed dwarfism, affecting about 1 in 15,000 to 40,000 births. It is caused by a mutation in the FGFR3 gene and is usually apparent at birth with characteristic features including short limbs, a larger head, and a prominent forehead. Intelligence is normal. With monitoring for specific complications and supportive care, children with achondroplasia lead full, active, and independent lives.
Adenoid Hypertrophy and Breathing
Adenoids are lymphoid tissue located behind the nose that help fight infection in young children. When adenoids become enlarged (adenoid hypertrophy), they can block the nasal airway, causing chronic mouth breathing, snoring, nasal speech, and sleep-disordered breathing. Enlarged adenoids are most common between ages 2-7 and are a leading cause of obstructive sleep apnea in young children. Treatment ranges from watchful waiting and nasal steroids to surgical removal (adenoidectomy) if breathing or sleep is significantly affected.
Air Quality and Baby Health
Babies and young children are more vulnerable to air pollution than adults because they breathe faster, their lungs are still developing, and they spend more time close to the ground where some pollutants concentrate. The EPA recommends keeping babies indoors when the Air Quality Index (AQI) exceeds 100 (orange level). During wildfire smoke events, keep windows closed, use air purifiers with HEPA filters, and monitor your child for coughing, wheezing, or difficulty breathing. Long-term exposure to air pollution can affect lung development.
Altitude Sickness in Babies
Babies and toddlers can experience altitude sickness when traveling above 5,000-8,000 feet (1,500-2,500 meters). Symptoms are harder to recognize in infants because they cannot describe how they feel. Watch for unusual fussiness, poor feeding, disrupted sleep, vomiting, and fast breathing. Gradual ascent is the best prevention. Most pediatricians recommend avoiding sleeping at very high altitudes (above 8,000 feet) with infants when possible, and descending immediately if symptoms appear.
Amblyopia (Lazy Eye) Treatment Timing
Amblyopia (lazy eye) is the most common cause of vision loss in children, affecting 2-3% of the population. It occurs when one eye develops weaker vision because the brain favors the other eye. Early detection and treatment are critical because the visual system is most responsive to treatment during early childhood. Treatment is most effective when started before age 7, though improvement is possible at older ages. Treatment options include patching the stronger eye, atropine eye drops, glasses, or a combination.